MACF1 Mediates the Impairment of Mechanical Unloading on Osteoblast Differentiation via F-Actin/ERK/Runx2 Axis
Cells · 2026
DOI: 10.3390/cells15161448 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Lifang Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Lab for Bone Metabolism, Xi'an Key Laboratory of Special Medicine and Health Engineering, Key Lab for Space Biosciences and Biotechnology, Research C…. Hauptthemen laut MEDLINE: Osteoblasts, Cell Differentiation, Actins, Core Binding Factor Alpha 1 Subunit. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the Natural Science Basic Research Plan in Shaanxi Province, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Decreased osteoblast differentiation contributes to bone loss induced by mechanical unloading. However, the underlying mechanism is still unclear. We previously found that microtubule actin crosslinking factor 1 (MACF1), a key cytoskeletal protein, plays an important role in regulating osteoblast differentiation, while the role of MACF1 in mechanical unloading suppressing osteoblast differentiation remains unclear. Here, an MACF1-knockdown (MACF1-KD) osteoblast cell line and primary osteoblasts were subjected to mechanical unloading conducted by a random positioning machine (RPM). Osteoblast differentiation was evaluated by alkaline phosphatase (ALP) staining and real-time PCR. F-actin distribution was examined by immunofluorescence staining. Western blot was adopted to detect the protein levels. Moreover, cytochalasin B and PD98059 were applied to disrupt F-actin and inhibit extracellular signal-regulated kinase (ERK) activity, respectively, to confirm the mechanism. The results show that MACF1 is significantly downregulated in osteoblasts by mechanical unloading together with decreased osteoblast differentiation. MACF1-KD osteoblasts exhibit reduced differentiation capacity and are insensitive to mechanical unloading. Mechanistically, MACF1 mediates the suppression of mechanical unloading on osteoblast differentiation by regulating F-actin distribution and the downstream ERK/Runx2 signaling. Furthermore, F-actin disruption and ERK inhibition assays confirm that MACF1 mediates the impairment of mechanical unloading on osteoblast differentiation via the F-actin/ERK/Runx2 axis. In conclusion, this study reveals MACF1 as a mechanotransduction mediator for mechanical unloading, inhibiting osteoblast differentiation via F-actin/ERK/Runx2, and contributes to a novel mechanistic insight of cell mechanotransduction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lab for Bone Metabolism, Xi'an Key Laboratory of Special Medicine and Health Engineering, Key Lab for Space Biosciences and Biotechnology, Research Center for Special Medicine and Health Systems Engineering, School of L…
ORCID-Profile: Lifang Hu, Kang Ru, Lei Qiao, Zhihao Chen, Airong Qian
Förderung
- National Natural Science Foundation of China
- the Natural Science Basic Research Plan in Shaanxi Province
- China Postdoctoral Science Foundation
Zitieren
APA
Hu, L., Ru, K., Zhong, W., Wang, L., Huang, Z., Qiao, L., Chen, Z., & Qian, A. (2026). MACF1 Mediates the Impairment of Mechanical Unloading on Osteoblast Differentiation via F-Actin/ERK/Runx2 Axis. Cells. https://doi.org/10.3390/cells15161448
Vancouver
Hu L, Ru K, Zhong W, Wang L, Huang Z, Qiao L, et al. MACF1 Mediates the Impairment of Mechanical Unloading on Osteoblast Differentiation via F-Actin/ERK/Runx2 Axis. Cells. 2026. doi:10.3390/cells15161448
BibTeX
@article{Hu2026,
author = {Hu, Lifang and Ru, Kang and Zhong, Wenjin and Wang, Linlin and Huang, Zizhan and Qiao, Lei and Chen, Zhihao and Qian, Airong},
title = {MACF1 Mediates the Impairment of Mechanical Unloading on Osteoblast Differentiation via F-Actin/ERK/Runx2 Axis},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15161448}
}
EUVIMED